Anticancer quinones induce pRb-preventable G2/M cell cycle arrest and apoptosis

Area of Science:

• Cell Biology
• Cancer Research
• Pharmacology

Background:

• The antitumor quinone 3,6-diaziridinyl-1,4-benzoquinone (DZQ) generates reactive oxygen species during metabolism.
• Reactive oxygen species can influence cell cycle regulation and apoptosis.
• p21 is an upstream regulator of the retinoblastoma gene product (pRb) and controls G1 cell cycle progression.

Purpose of the Study:

• To investigate the effects of DZQ on cell cycle control and apoptosis in cancer cells.
• To determine the role of p53 and pRb in DZQ-induced cellular responses.
• To elucidate the relationship between p21 induction and DZQ-mediated cell cycle arrest and apoptosis.

Main Methods:

• Treatment of human colonic carcinoma HCT116 cells and human osteosarcoma Saos-2 cells (lacking p53 and pRb) with DZQ.
• Analysis of cell cycle phase distribution using flow cytometry.
• Assessment of apoptosis using relevant assays.
• Transfection of Saos-2 cells with the Rb gene.

Main Results:

• DZQ induced G2/M cell cycle arrest and apoptosis in both HCT116 and Saos-2 cells.
• DZQ treatment led to increased p21 levels in Saos-2 cells.
• Transfection of the Rb gene into Saos-2 cells shifted cell cycle arrest to G1 phase and prevented apoptosis, without altering p21 induction levels.

Conclusions:

• DZQ can induce a p53-independent G2/M cell cycle arrest and apoptosis.
• The retinoblastoma gene product (pRb) plays a role in preventing DZQ-induced G2/M arrest and apoptosis.
• p21 induction correlates with DZQ-mediated G2/M arrest and apoptosis, suggesting a complex regulatory mechanism.